The MFDS monitors off-label drug use to ensure patient safety. While physicians may prescribe drugs off-label, the MFDS provides guidelines to minimize risks. It requires that any off-label use be supported by clinical evidence, and manufacturers cannot promote off-label uses. Post-market surveillance helps track safety outcomes.